[Characteristics and failure risk factors of sequential high-flow nasal cannula oxygen therapy after weaning from invasive ventilation in patients of surgical intensive care unit].
Journal
Zhonghua wei zhong bing ji jiu yi xue
ISSN: 2095-4352
Titre abrégé: Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
Pays: China
ID NLM: 101604552
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
entrez:
19
7
2019
pubmed:
19
7
2019
medline:
19
9
2019
Statut:
ppublish
Résumé
To investigate the characteristics and failure risk factors of sequential high-flow nasal cannula oxygen therapy (HFNC) after weaning from invasive ventilation. The patients who received sequential HFNC after weaning from invasive ventilation admitted to surgical intensive care unit (ICU) of Peking University People's Hospital from June 1st 2016 to May 31st 2018 were retrospectively analyzed. Clinical variables, respiratory therapy parameters, respiratory variables, cardiac variables and outcomes were reviewed and analyzed. Treatment characteristics of HFNC after weaning was analyzed. Patients were divided into HFNC success group and HFNC failure group according to the failure of HFNC, and the differences between the two groups were compared. The independent risk factors of HFNC treatment failure were analyzed by Logistic regression analysis. The value of predictive treatment failure of risk factors and regression models were analyzed by receiver operating characteristic (ROC) curve. A total of 99 patients were included, 61 men, and the median age was 67.0 (57.0, 76.0) years old. The medianinitial HFNC flow was 50 (50, 60) L/min, and inspired oxygen concentration (FiO HFNC is one of the commonly used oxygen therapy methods in the ICU, but not all patients who are treated as a sequential therapy after invasive mechanical ventilation weaning can benefit from it. SOFA score, BNP before HFNC treatment and HR after 30 minutes HFNC treatment were independent risk factors of HFNC failure. Each independent risk factor and regression model can predict the success of HFNC treatment.
Identifiants
pubmed: 31315724
doi: 10.3760/cma.j.issn.2095-4352.2019.06.006
doi:
Types de publication
Journal Article
Langues
chi
Sous-ensembles de citation
IM